Notices. Notice of application
409 words·~2 min read·
/register/2018/02/20/2018-03293A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Bulk Manufacturer of Controlled Substances Application: Johnson Matthey Inc. ACTION: Notice of application. DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before April 23, 2018. ADDRESSES: Written comments should be sent to:
Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (“Deputy Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on November 09, 2017, Johnson Matthey Inc., 2003 Nolte Drive, West Deptford, NJ 08066, applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: Controlled substance Drug code Schedule Gamma Hydroxybutyric Acid 2010 I Marihuana 7360 I Tetrahydrocannabinols 7370 I Dihydromorphine 9145 I Difenoxin 9168 I Propiram 9649 I Amphetamine 1100 II Methamphetamine 1105 II Lisdexamfetamine 1205 II Methylphenidate 1724 II Nabilone 7379 II Cocaine 9041 II Codeine 9050 II Dihydrocodeine 9120 II Oxycodone 9143 II Hydromorphone 9150 II Diphenoxylate 9170 II Ecgonine 9180 II Hydrocodone 9193 II Meperidine 9230 II Methadone 9250 II Methadone intermediate 9254 II Morphine 9300 II Thebaine 9333 II Oxymorphone 9652 II Noroxymorphone 9668 II Alfentanil 9737 II Remifentanil 9739 II Sufentanil 9740 II Tapentadol 9780 II Fentanyl 9801 II The company plans to manufacture the above-listed controlled substances in bulk for sale to its customers.
Thebaine
(9333)will be used to manufacture other controlled substances for sale in bulk to its customers. In reference to drug codes 7360 (marihuana), and 7370 (THC), the company plans to bulk manufacture these drugs as synthetics. No other activities for these drug codes are authorized for this registration. Dated: February 6, 2018. Susan A. Gibson, Deputy Assistant Administrator. [FR Doc. 2018-03293 Filed 2-16-18; 8:45 am]
Connectionstraces to 2
2 references not yet in our index
- 21 CFR 1301
- 28 CFR 0
Citation graph
cites case law
Cites 4Cited by 0 across 0 sources